A tunneled dialysis catheter has one job: to move enough blood, in and out, for effective dialysis. Over time many of them stop doing it well. A fibrin sheath forms around the catheter tip, or thrombus builds inside the lumen, and blood flow falls below what the dialysis machine needs. The treatment slows, alarms, or has to be cut short.
When that happens, the options today are disruptive. A thrombolytic such as alteplase can be instilled to try to dissolve the obstruction, but it may sit in the general lumen rather than reaching the blockage; when it fails, patients are often sent for a catheter exchange, an extra clinic or emergency visit, or a missed dialysis appointment. This program is designed to make catheter clearance a routine, in-chair step instead.
The system pairs a compact infuser with a minimally modified, standard angiographic-style catheter carrying radiopaque markers. Rather than flooding the lumen, it is designed to deliver the thrombolytic agent precisely at the site of the blockage, using standard low-pressure application, so the medication can act where the obstruction actually is.
It is built as a closed system, intended to keep the circuit sealed throughout — preventing air entry and blood loss during the procedure and supporting sterility. In practice, the intent is a device that a clinician can deploy with a single button press to begin restoring flow, without disassembling or exchanging the patient's access.
Because access failures happen wherever patients are dialyzed, the device is designed to fit those settings rather than a procedure suite. It is intended to arrive sterile and ready to use, to require minimal additional staff training, and to work with standard central lines. It is designed as a single-use, disposable item, so there is nothing to reprocess between patients.
The goal is simple to state: keep the catheter the patient already has working, and keep the patient on schedule.
Catheter malfunction is one of the most common and repetitive disruptions in chronic hemodialysis. Each failed clearance can mean an invasive procedure, a lost treatment slot, and added burden on both the patient and the dialysis unit. By making effective, targeted clearance faster and repeatable at the point of care, this program is intended to reduce catheter exchanges and unplanned visits — and to help patients keep the dialysis schedule their health depends on.
Investigational status: Principal Medical's portfolio platforms and the products referenced here are currently in development and are not yet cleared or approved by the U.S. Food and Drug Administration.